HIV Outbreak Control With Effective Access to Care and Harm Reduction in North Carolina, 2017–2018
Bibliographic Data
Objectives. To assess and control a potential outbreak of HIV among people who inject drugs in Western North Carolina. Methods. Disease intervention specialists offered testing for hepatitis B and hepatitis C, harm reduction materials, and linkage to care to 7 linked people recently diagnosed with HIV who also injected drugs. Contacts were offered the same services and HIV testing. HIV genotype analysis was used to characterize HIV spread. We assessed testing and care outcomes by using state surveillance information. Results. Disease intervention specialists contacted 6 of 7 linked group members and received information on 177 contacts; among 96 prioritized contacts, 42 of 96 (44%) were exposed to or diagnosed with hepatitis C, 4 of 96 (4%) had hepatitis B, and 14 of 96 (15%) had HIV (2 newly diagnosed during the investigation). HIV genotype analysis suggested recent transmission to linked group members and 1 contact. Eleven of 14 with HIV were virally suppressed following the outbreak response. Conclusions. North Carolina identified and rapidly responded to an HIV outbreak among people reporting injecting drugs. Effective HIV care, the availability of syringe exchange services, and the rapid response likely contributed to controlling this outbreak
Environmental health · Family medicine · Harm reduction · Hepatitis C · Human immunodeficiency virus (HIV) · Intervention (counseling) · Outbreak · Psychiatry · Transmission (telecommunications) · HIV Research and Treatment · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Virology
Factors associated with loss to follow up among HIV-exposed children
Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs
Study protocol for an efficacy trial of the “PrEP for Health” intervention to increase HIV PrEP use among people who inject drugs
Heroin, Fentanyl, Intentional Fentanyl Use and HIV Transmission in a Community-Recruited Sample of Persons Who Inject Drugs, New York City
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program
Supportive environments during the substance use disorder epidemic in the rural United States
County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States
Injection risk behaviors among rural drug users
Risk Factors for HCV Infection Among Young Adults in Rural New York Who Inject Prescription Opioid Analgesics
Individual and Network Factors Associated With Prevalent Hepatitis C Infection Among Rural Appalachian Injection Drug Users
Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in Connecticut
| Citations per year | 1 |
|---|---|
| Citation span | 2020 - 2025 (6) |
| Highly cited | No |